USSTOCK.TODAY
Market Closed
Log in Sign up

FDA Lifts Clinical Hold on Aardvark Therapeutics' ARD-101

Nasdaq +1 · ·by G4L

AARD
AARD Aardvark Therapeutics Inc
$1.59 +16.06%
View chart & analysis →
  1. 1The FDA has lifted the clinical hold on Aardvark Therapeutics' drug candidate ARD-101.
  2. 2Aardvark Therapeutics shares rose 21% in Thursday after-hours trading.
  3. 3Aardvark Therapeutics conducted clinical trials using 200 mg and 400 mg doses administered twice daily.

So what's the key point?

The U.S. Food and Drug Administration lifted its order to stop drug testing for Aardvark Therapeutics. Following this news, the stock price rose by 21 percent.

Source Nasdaq +1 · View original ↗

Related 3-line summaries

Class action lawsuit filed regarding Aardvark Therapeutics, Inc. stock Newsfile · Oct 6Netflix shares rebound following sell-off after earnings report The Motley Fool +1 · Oct 23Boston Beer Q3 Earnings Beat Estimates Associated Press +4 · Oct 23
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news